A Phase II Study Investigating Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder
Latest Information Update: 04 Nov 2022
At a glance
- Drugs Bintrafusp alfa (Primary)
- Indications Adenocarcinoma; Bladder cancer; Carcinoma; Squamous cell cancer; Urogenital cancer
- Focus Therapeutic Use
- Acronyms PEBBLE
- 28 Apr 2022 This trial has been discontinued in Spain, according to European Clinical Trials Database record
- 01 Jul 2021 Status changed from recruiting to active, no longer recruiting.
- 01 Jul 2021 Status changed from not yet recruiting to recruiting.